Priming and Maintenance of Adaptive Immunity in the Liver
- PMID: 38360545
- DOI: 10.1146/annurev-immunol-090122-041354
Priming and Maintenance of Adaptive Immunity in the Liver
Abstract
The liver's unique characteristics have a profound impact on the priming and maintenance of adaptive immunity. This review delves into the cellular circuits that regulate adaptive immune responses in the liver, with a specific focus on hepatitis B virus infection as an illustrative example. A key aspect highlighted is the liver's specialized role in priming CD8+ T cells, leading to a distinct state of immune hyporesponsiveness. Additionally, the influence of the liver's hemodynamics and anatomical features, particularly during liver fibrosis and cirrhosis, on the differentiation and function of adaptive immune cells is discussed. While the primary emphasis is on CD8+ T cells, recent findings regarding the involvement of B cells and CD4+ T cells in hepatic immunity are also reviewed. Furthermore, we address the challenges ahead and propose integrating cutting-edge techniques, such as spatial biology, and combining mouse models with human sample analyses to gain comprehensive insights into the liver's adaptive immunity. This understanding could pave the way for novel therapeutic strategies targeting infectious diseases, malignancies, and inflammatory liver conditions like metabolic dysfunction-associated steatohepatitis and autoimmune hepatitis.
Keywords: B cells; T cells; exhaustion; hepatitis; immunotherapy; liver.
Similar articles
-
Adaptive response in hepatitis B virus infection.J Viral Hepat. 2014 May;21(5):305-13. doi: 10.1111/jvh.12255. Epub 2014 Mar 27. J Viral Hepat. 2014. PMID: 24674098 Review.
-
CD40 activation rescues antiviral CD8⁺ T cells from PD-1-mediated exhaustion.PLoS Pathog. 2013;9(7):e1003490. doi: 10.1371/journal.ppat.1003490. Epub 2013 Jul 11. PLoS Pathog. 2013. PMID: 23853599 Free PMC article.
-
Hepatitis B virus: from immunobiology to immunotherapy.Clin Sci (Lond). 2013 Jan;124(2):77-85. doi: 10.1042/CS20120169. Clin Sci (Lond). 2013. PMID: 23013042 Review.
-
IL-12-based vaccination therapy reverses liver-induced systemic tolerance in a mouse model of hepatitis B virus carrier.J Immunol. 2013 Oct 15;191(8):4184-93. doi: 10.4049/jimmunol.1203449. Epub 2013 Sep 18. J Immunol. 2013. PMID: 24048897
-
Lentiviral vector encoding ubiquitinated hepatitis B core antigen induces potent cellular immune responses and therapeutic immunity in HBV transgenic mice.Immunobiology. 2016 Jul;221(7):813-21. doi: 10.1016/j.imbio.2016.01.015. Epub 2016 Feb 2. Immunobiology. 2016. PMID: 26874581
Cited by
-
Therapeutic potential of co-signaling receptor modulation in hepatitis B.Cell. 2024 Jul 25;187(15):4078-4094.e21. doi: 10.1016/j.cell.2024.05.038. Epub 2024 Jun 18. Cell. 2024. PMID: 38897196 Free PMC article.
-
Myeloid cells in chronic liver inflammation.Cell Mol Immunol. 2025 Jul 28. doi: 10.1038/s41423-025-01324-4. Online ahead of print. Cell Mol Immunol. 2025. PMID: 40721870 Review.
-
Cytokine Response of Natural Killer Cells to Hepatitis B Virus Infection Depends on Monocyte Co-Stimulation.Viruses. 2024 May 8;16(5):741. doi: 10.3390/v16050741. Viruses. 2024. PMID: 38793623 Free PMC article.
-
Granulomatous inflammatory responses are elicited in the liver of PD-1 knockout mice by de novo genome mutagenesis.Discov Immunol. 2024 Dec 25;4(1):kyae018. doi: 10.1093/discim/kyae018. eCollection 2025. Discov Immunol. 2024. PMID: 39839810 Free PMC article.
-
Causal association between 731 immunocyte phenotypes and liver cirrhosis: A bidirectional two-sample mendelian randomization analysis.World J Hepatol. 2024 Aug 27;16(8):1156-1166. doi: 10.4254/wjh.v16.i8.1156. World J Hepatol. 2024. PMID: 39221101 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials